OCTOBER BREAST CANCER AWARENESS MONTH

Breast Cancer Awareness Month is an international health campaign, dedicated to increasing awareness about screening and prevention for a disease that affects approximately 2.3 million women worldwide (1).

Breast cancer is the most common cancer among women and the leading most common cancer diagnosis (2). Although it mainly affects women, men can also develop malignant breast tissue (3). Male breast cancer is rare, making up about 1% of all cases, but men are often diagnosed at more advanced stages. This delay in seeking medical attention frequently results in later detection and less favorable outcome.

OCTOBER BREAST CANCER AWARENESS MONTH

Detecting breast cancer early greatly enhances the chances of successful treatment, resulting in higher survival rates, less intensive therapies, and improved quality of life. Key early detection strategies include routine mammograms, clinical breast exams, and being attentive (4) .Early detection of breast cancer significantly improves successful outcomes by leading to higher survival rates, less aggressive treatment options, and a better quality of life (4).

Learn about Personalized Early Detection and Prevention of Breast Cancer:

– Breast cancer: A review of risk factors and diagnosis. Medicine (Baltimore). Obeagu EI et al.,  2024.   

– Breast Cancer Awareness Month 2025 UK | Breast Cancer Now

– October is Breast Cancer Awareness Month – American Association of Cancer Research 

– Breast Cancer Awareness Month 2025, World Health Organization

– Personalized early detection and prevention of breast cancer: ENVISION consensus statement. Pashayan N et al.,  2020.

Abstract

The European Collaborative on Personalized Early Detection and Prevention of Breast Cancer (ENVISION) brings together several international research consortia working on different aspects of the personalized early detection and prevention of breast cancer. In a consensus conference held in 2019, the members of this network identified research areas requiring development to enable evidence-based personalized interventions that might improve the benefits and reduce the harms of existing breast cancer screening and prevention programmes. The priority areas identified were: 1) breast cancer subtype-specific risk assessment tools applicable to women of all ancestries; 2) intermediate surrogate markers of response to preventive measures; 3) novel non-surgical preventive measures to reduce the incidence of breast cancer of poor prognosis; and 4) hybrid effectiveness-implementation research combined with modelling studies to evaluate the long-term population outcomes of risk-based early detection strategies. The implementation of such programmes would require health-care systems to be open to learning and adapting, the engagement of a diverse range of stakeholders and tailoring to societal norms and values, while also addressing the ethical and legal issues. In this Consensus Statement, we discuss the current state of breast cancer risk prediction, risk-stratified prevention and early detection strategies, and their implementation. Throughout, we highlight priorities for advancing each of these areas.

 

BIOMEDICA offers fully validated Biomarker ELISA Kits for Breast Cancer Research

PERIOSTIN ▪ NEUROPILIN-1 ▪ OSTEPROTEGERIN ▪ soluble RANKL ▪ SEMAPHORIN 4D ▪ IL-6

click here for more information on our Biomarker ELISAs in Oncology

 

ELISA Assay Kit Highlights

• EASY –ready to use calibrators & controls included (color-coded reagents)
• FULL VALIDATION PACKAGE – assays are optimized for clinical samples
• HIGH QUALITY GUARANTEED – results you can rely on
• WIDELY CITED in over 1000 publications

 

BIOMEDICA – Complete ready-to-use ELISA kits for superior performance and reproducibility

 

 

Literature

1. Breast Cancer Awareness Month 2025, World Health Organization
2. Breast cancer: presentation, investigation and management. Katsura C, Ogunmwonyi I, Kankam HK, Saha S. Br J Hosp Med (Lond). 2022 Feb 2;83(2):1-7. doi: 10.12968/hmed.2021.0459. PMID: 35243878.
3. Male Breast Cancer. Khattab A, Kashyap S, Monga DK. 2024 Sep 10. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30252292.